BRIEF-Pfizer Inc Reports Passive Stake Of 4.96% In Tourmaline Bio Inc As Of Jan 29-March 2024-www.financetom.com

BRIEF-Pfizer Inc Reports Passive Stake Of 4.96% In Tourmaline Bio Inc As Of Jan 29

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Pfizer Inc Reports Passive Stake Of 4.96% In Tourmaline Bio Inc As Of Jan 29

Mar 15, 2024 5:13 AM

March 15 (Reuters) - Pfizer Inc ( PFE ):

* PFIZER INC REPORTS PASSIVE STAKE OF 4.96% IN TOURMALINE

BIO INC

AS OF JAN 29, 2024 VERSUS. 6.26% AS OF OCT 19, 2023

Source text for Eikon:

Further company coverage:

Previous page： Billionaire wealth reaches new high during COVID-19 pandemic: UBS Next page： Mahadev app scam case: Shraddha Kapoor to appear before ED today, Ranbir seeks two weeks to appear

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Billionaire wealth reaches new high during COVID-19 pandemic: UBS

Oct 7, 2020

Between April 7 and July 31 this year, billionaires across every industry covered by the study saw their wealth rise by double digits, with billionaires in the technology, healthcare and industrial sectors leading the pack with 36 percent-44 percent gains.

Mahadev app scam case: Shraddha Kapoor to appear before ED today, Ranbir seeks two weeks to appear

Oct 5, 2023

Mahadev app scam case: Shraddha Kapoor is accused of promoting the illegal app and the financial probe agency suspects that the payments she received were proceeds of crime.

Black cab drivers says Uber decision is a 'disaster' for London

Sep 28, 2020

The association representing London black cab drivers said a judge's decision to restore Uber's operating licence on Monday was a "disaster" for the British capital.

Meet the man who dethroned Jack Ma to become China's wealthiest person

Sep 24, 2020

The April listing of vaccine maker Beijing Wantai Biological Pharmacy Enterprise Co pushed Zhong's net worth to $20 billion by early August.